Aspen Pharmacare Return On Asset vs. Revenue
| APN Stock | 16,565 34.00 0.20% |
For Aspen Pharmacare profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Aspen Pharmacare to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Aspen Pharmacare Holdings utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Aspen Pharmacare's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Aspen Pharmacare Holdings over time as well as its relative position and ranking within its peers.
Aspen |
Aspen Pharmacare Holdings Revenue vs. Return On Asset Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Aspen Pharmacare's current stock value. Our valuation model uses many indicators to compare Aspen Pharmacare value to that of its competitors to determine the firm's financial worth. Aspen Pharmacare Holdings is number one stock in return on asset category among its peers. It also is the top company in revenue category among its peers totaling about 773,667,334,669 of Revenue per Return On Asset. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Aspen Pharmacare's earnings, one of the primary drivers of an investment's value.Aspen Revenue vs. Return On Asset
Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Aspen Pharmacare |
| = | 0.0499 |
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Aspen Pharmacare |
| = | 38.61 B |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Aspen Revenue vs Competition
Aspen Pharmacare Holdings is the top company in revenue category among its peers. Market size based on revenue of Drug Manufacturers-Specialty & Generic industry is presently estimated at about 62.18 Billion. Aspen Pharmacare totals roughly 38.61 Billion in revenue claiming about 62% of equities under Drug Manufacturers-Specialty & Generic industry.
Aspen Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Aspen Pharmacare. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Aspen Pharmacare position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Aspen Pharmacare's important profitability drivers and their relationship over time.
Use Aspen Pharmacare in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aspen Pharmacare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aspen Pharmacare will appreciate offsetting losses from the drop in the long position's value.Aspen Pharmacare Pair Trading
Aspen Pharmacare Holdings Pair Trading Analysis
The ability to find closely correlated positions to Aspen Pharmacare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aspen Pharmacare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aspen Pharmacare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aspen Pharmacare Holdings to buy it.
The correlation of Aspen Pharmacare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aspen Pharmacare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aspen Pharmacare Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aspen Pharmacare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Aspen Pharmacare position
In addition to having Aspen Pharmacare in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Disruptive Technologies Thematic Idea Now
Disruptive Technologies
New or established technology companies and funds across multiple sectors that are involved in development or marketing of products or services that experience disruptive trends and that are at the forefront of discussions on Wall Street. The Disruptive Technologies theme has 64 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Disruptive Technologies Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Aspen Stock
To fully project Aspen Pharmacare's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Aspen Pharmacare Holdings at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Aspen Pharmacare's income statement, its balance sheet, and the statement of cash flows.